MASI

Masimo Corporation

MASI.US masimo.com + Research + Basket
CIK 0000937556
Employees 2,200
Phone 949 297 7000
Fiscal year end December
IPO Aug 08, 2007
Address 52 Discovery, Irvine, CA, United States, 92618
Price N/A
USD · NASDAQ
52-week range
125.94
179.99
Market Cap
9.42B
P/E Ratio
44.43
Forward P/E
40.82
Book Value
15.07
Div. Yield
N/A
% Institutions
104.78%
% Insiders
6.22%

1 Year

+8.8%

3 Year

+12.5%

10 Year

+249.1%
Description

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Actions

Add an action for MASI.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Ms. Catherine M. Szyman CEO & Director 1967
Mr. Micah Young CPA Executive VP & CFO 1979
Mr. Anand Sampath Executive Vice President of Operations 1966
Mr. Charles Dadswell Executive VP & General Counsel 1959
Mr. Greg Meehan Chief Commercial Officer 1964
Mr. Paul Hataishi Senior VP & Chief Accounting Officer 1975
Mr. Yongsam Lee Executive VP & Chief Information Officer 1965
Dr. Steven J. Barker Chairman of Scientific Advisory Board & Chief Science Officer 1945
Mr. Matthew Brinckman Senior Vice President of FP&A and Investor Relations NA
Mr. Tim A. Benner Chief Marketing & Strategy Officer 1968

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Sep 26, 2025 Kevin Hern N/A Sale N/A $141.40 N/A —
Aug 12, 2025 Michelle Brennan N/A Purchase 100.00 $150.35 $15.04K SEC
Aug 11, 2025 William R Jellison N/A Purchase 3.00K $145.98 $437.94K SEC
May 12, 2025 Bilal Muhsin N/A Sale 10.00K $163.28 $1.63M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 4.64M Mar 31, 2026 8.87% $0.01 -47.55%
Politan Capital Management LP 4.59M Mar 31, 2026 8.76% $82.89 0.00%
Vanguard Group Inc 4.35M Dec 31, 2025 8.30% $0.01 -9.59%
Pentwater Capital Management LP 3.18M Mar 31, 2026 6.07% $2.93 0.00%
Barclays PLC 2.74M Mar 31, 2026 5.24% $0.12 4,601.99%
HBK INVESTMENTS L P 2.58M Mar 31, 2026 4.92% $4.65 0.00%
Massachusetts Financial Services Company 2.34M Mar 31, 2026 4.47% $0.14 -12.05%
Vanguard Capital Management, LLC 2.05M Mar 31, 2026 3.91% $0.01 0.00%
Vanguard Portfolio Management, LLC 2.01M Mar 31, 2026 3.83% $0.02 0.00%
FMR Inc 1.45M Mar 31, 2026 2.77% $0.01 -81.55%
State Street Corp 1.44M Mar 31, 2026 2.75% $0.01 1.59%
Millennium Management LLC 988.85K Mar 31, 2026 1.89% $0.07 426.08%
The Goldman Sachs Group Inc 984.19K Mar 31, 2026 1.88% $0.02 54.58%
Geode Capital Management, LLC 956.74K Mar 31, 2026 1.83% $0.01 0.29%
AQR Capital Management LLC 831.97K Mar 31, 2026 1.59% $0.07 -23.77%
Balyasny Asset Management LLC 770.99K Mar 31, 2026 1.47% $0.18 0.00%
Morgan Stanley - Brokerage Accounts 752.42K Mar 31, 2026 1.44% $0.01 -18.28%
JPMorgan Chase & Co 572.65K Mar 31, 2026 1.09% $0.01 386.12%
Citigroup Inc 533.39K Mar 31, 2026 1.02% $0.04 339.98%
SG Americas Securities, LLC 522.82K Mar 31, 2026 1.00% $0.10 3,082.32%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 MFS Mid Cap Growth Equity 1.64M 3.12% ▼ 0.46% Mar 31, 2026
2 MFS Mid Cap Growth A 1.64M 3.12% ▲ 0.00% May 31, 2026
3 BlackRock Global Uncons Eq Z USD Acc 1.07M 2.04% ▼ 0.85% Oct 31, 2025
4 BlackRock Event Driven Equity Instl 971.82K 1.86% ▲ 0.00% May 31, 2026
5 BlackRock GlbUncons Eq Fd (UK) Z GBPAcc 445.25K 0.85% ▲ 0.68% Oct 31, 2025
6 First Trust Merger Arbitrage Cl I 402.12K 0.77% ▲ 0.00% Mar 31, 2026
7 MFS Mid Cap Growth fund Class 2 375.74K 0.72% ▲ 1.38% May 31, 2026
8 State Street® SPDR® S&P MIDCAP 400® ETF 342.05K 0.65% ▼ 0.98% May 31, 2026
9 American Funds SMALLCAP World A 317.33K 0.61% ▼ 43.89% Mar 31, 2026
10 NexPoint Merger Arbitrage Z 297.50K 0.57% ▲ 0.00% Mar 31, 2026

Financial Highlights

▼
Market Cap: $9.42B
EBITDA: $367.70M
P/E Ratio: $44.43
PEG Ratio: $4.83
Book Value: $15.07
Earnings/Share: $4.05
Profit Margin: 4.90%
Operating Margin: 23.61%
ROA (TTM): 10.20%
ROE (TTM): 24.99%
Revenue (TTM): $1.56B
Revenue/Share (TTM): $29.32
Earnings Growth (YOY): 214.40%
Revenue Growth (YOY): 8.50%

Valuation Metrics

Enterprise Value: $9.79B
Trailing P/E: 44.43
Forward P/E: 40.82

Shares Statistics

Shares Outstanding: 52.37M
Shares Float: 44.31M
% Insiders: 6.22%
% Institutions: 104.78%
Short % Float: 7.34%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$1.53B
Cost of Goods Sold
adjust
$-581.70M
Gross Profit
subtotal
$945.20M
SG&A
adjust
$-506.00M
R&D
adjust
$-126.40M
Operating Income
subtotal
$312.80M
Other / Non-Operating Items
adjust
$-464.30M
Net Income
subtotal
$-151.50M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MASI.US!